Andere talen Cerevel Therapeutics Holdings, Inc.

Aandelen

CERE

US15678U1280

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 03-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
40,63 ^USD	-0,27%		-1,69%	-4,17%

14/05	Cerevel Therapeutics Holdings Insider verkocht aandelen ter waarde van $2.105.125, volgens een recente SEC filing	MT
08/05	Cerevel Therapeutics Holdings, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Cerevel Therapeutics Holdings Insider Sold Shares Worth $2,105,125, According to a Recent SEC Filing	14/05
Cerevel Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Cerevel Therapeutics' Parkinson's disease drug meets main goal in late-stage study	18/04
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson?s Disease	18/04
Actinogen Medical Notifies of Errors on M&A Slide in Recent Presentation	25/03
Cerevel Therapeutics Holdings Insider Sold Shares Worth $2,057,890, According to a Recent SEC Filing	04/03
Cerevel Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Sector Update: Health Care Stocks Gain Late Afternoon	22/02
AbbVie Plans $13 Billion Bond Sale to Fund Acquisitions	22/02
AbbVie eyes selling at least $13 bln of bonds to fund M&A, Bloomberg reports	22/02
AbbVie CEO to Retire; COO Robert Michael Named Successor	20/02
CEREVEL THERAPEUTICS HOLDINGS, INC. : Mizuho Securities conserve son opinion neutre	15/02
BioPharma Credit gets USD50.6 million from Abbvie's ImmunoGen purchase	13/02
AbbVie Completes $10.1 Billion Acquisition of ImmunoGen, Lowers Q1 Adjusted EPS Guidance	12/02
Omzetdaling Abbvie valt mee	02/02
AbbVie profit beats estimates as Humira, Botox sales weather hit from rivals	02/02
Neumora Therapeutics Names Kaya Pai Panandiker as Chief Commercial Officer	22/01
Cerevel Therapeutics Holdings Insider Sold Shares Worth $424,700, According to a Recent SEC Filing	28/12
CEREVEL THERAPEUTICS HOLDINGS, INC. : JPMorgan Chase maintient sa recommandation neutre	28/12
Cerevel Therapeutics Holdings Insider Sold Shares Worth $331,608, According to a Recent SEC Filing	27/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cerevel Therapeutics Holdings, Inc.

Aandelen

CERE

US15678U1280

Andere talen

Filters